FLEURS CBD LEMON HAZE

The legend says that its CBD flowers are unforgettable.

Discover the CBD Lemon Haze flower, a lemony flower for a tangy experience with citrus smells that will not leave you indifferent.

Taste the pleasure of an outdoor flower with a new and intense smell mixing lemon and haze. Now available at SMC Laboratories®, Swiss CBD specialist.

Our CBD Lemon Haze flower genetics are grown outdoors in the best conditions to guarantee you a quality organic product without pesticides, heavy metals or GMOs.

Once finished, we guarantee a curing of 3 to 8 weeks so that the terpenes take all their rise and that the organoleptic qualities reach their apogee allowing thesmell of the flower to transcend all your senses.

Agricultural hemp*(100%)
Cannabidiol (CBD) less than 10%.
THC less than 0.2%.

*Resulting from organic agriculture and the common catalog of varieties of European agricultural species.
Guaranteed without pesticides, fungicides, chemical fertilizers, heavy metals, additives or allergens.

For private use only.
Do not smoke.

Store in a dry place.

Use by date indicated on the packaging.

Fleurs Européennes :
Chaque batch de Fleurs de chanvre expédié en Europe fait ainsi l’objet d’une analyse par un laboratoire indépendant en Suisse, puis d’une contre-analyse par un acteur indépendant en Europe.
Ces deux contrôles de sécurité assurent que nos fleurs mise sur le marché respectent scrupuleusement la réglementation Européenne en matière de Taux de THC (<0,2%).
Nous nous assurons également que les fleurs de chanvre proviennent du catalogue Européen Des variétés agricoles autorisées.

Flowers sold CBD Switzerland:
As required by our country's regulations, we assure our Swiss customers that the flowers sold by our company are at a THC level lower than 1%.

All these data are the property of the company SWISS MEDICAL CANNABIS SA. specialized in CBD Switzerland, by the directives 91/250/CEE and 96/9/CE which grant respectively the protection of the copyright to the computer programs and to the data bases. SWISS MEDICAL CANNABIS SA. reserves the right to take legal action against any copy or reproduction of our information.

We also reserve the right to file a claim for damages, in accordance with article L. 331-1-3 of the CPI, which states that "in order to determine the damages, the court shall take into consideration the negative economic consequences, including loss of earnings, suffered by the injured party, the profits made by the infringer and the moral prejudice caused to the owner of these rights as a result of the infringement.